stockrowCodexis, Inc. (CDXS) vs Humacyte, Inc. (HUMA)
- Codexis, Inc. CDXS 1.07 +4.90%
- Humacyte, Inc. HUMA 0.44 +10.00%
Codexis, Inc. and Humacyte, Inc. are both Biotechnology companies. Codexis, Inc. and Humacyte, Inc. are of similar size ($111.7M and $109.9M). Humacyte, Inc. grew revenue faster over the last twelve months: 149.8% against 35.9%. Codexis, Inc. has the higher net margin (−39.6% vs −4,448.9%) and the higher return on invested capital (−151.2% vs −433.7%). Across the 17 metrics below, Codexis, Inc. leads on 13 and Humacyte, Inc. on 4.
Valuation
Profitability
| Metric | CDXS | HUMA | Biotechnology median |
|---|---|---|---|
| Gross margin | 87.02% | (494.58%) | 68.51% |
| Operating margin | (35.61%) | (5,240.78%) | 0.00% |
| Net margin | (39.55%) | (4,448.89%) | 0.00% |
| Free cash flow margin | (15.66%) | (4,599.72%) | 0.00% |
| Return on equity | (69.36%) | (534.42%) | (51.96%) |
| Return on assets | (23.79%) | (68.16%) | (46.06%) |
| Return on invested capital | (151.17%) | (433.66%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack